Start of phase I clinical trial with SM101
 |  |  |
04.05.2009
SuppreMol announces the start of a phase I clinical trial with its lead compound SM101.
 | 55 kB |
| | |
04.05.2009
SuppreMol announces the start of a phase I clinical trial with its lead compound SM101.
| 55 kB |